Company performance
Add to research
Current Price
as of Feb 07, 2025$39.37
P/E Ratio
N/A
Market Cap
$2.28B
Description
Add to research
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerJANX
- Price$39.37-3.22%
Trading Information
- Market cap$2.28B
- Float82.71%
- Average Daily Volume (1m)991,718
- Average Daily Volume (3m)1,177,480
- EPS-$1.18
Company
- Revenue$13.05M
- Rev growth (1yr)-82.56%
- Net income-$28.06M
- Gross margin-16.17%
- EBITDA margin-8,048.29%
- EBITDA-$35.33M
- EV$1.85B
- EV/Revenue141.56
- P/EN/A
- P/S164.82
- P/B3.14
- Debt/Equity3.57
Documents
Add to research
SEC Filings